Tag Archives: Actos
-
Drug manufacturers are challenged to create safe drugs that target a specific condition in the human body. The research and development process inevitably reaps more failures than successes. When a blockbuster drug is created, it becomes a cash cow for pharmaceutical companies, while hopefully providing improved treatment options for patients. But the challenge of creating… Read More »
-
Actos® — or pioglitazone — is a drug designed to treat type 2 diabetes by making it easier to regulate blood sugar levels. But in August 2011, the FDA issued a warning regarding the drug, noting that it had been linked to an increased risk of bladder cancer. Moreover, Actos may cause or worsen congestive… Read More »
-
Doctors and attorneys across the nation are warning patients about a link between taking the diabetes drug Actos and the development of bladder cancer. Although the U.S. Food and Drug Administration (FDA) approved Actos for the treatment of diabetes in 1999, pre-approval studies found that a correlation between Actos and bladder cancer existed in lab… Read More »
